Literature DB >> 12869365

Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney.

Tho D Pham1, Nicole K MacLennan, Christina T Chiu, Gisella S Laksana, Jennifer L Hsu, Robert H Lane.   

Abstract

Uteroplacental insufficiency causes intrauterine growth retardation (IUGR), which is associated with adult onset diseases such as hypertension. Previous studies demonstrate that growth retardation in humans and rats decreases glomeruli number; however, the molecular mechanisms responsible for this reduction are unknown. Apoptosis plays a key role in renal organogenesis. We therefore hypothesized that the in utero deprivation associated with uteroplacental insufficiency decreases glomeruli, increases apoptosis, and alters the mRNA levels of key apoptosis-related proteins in full-term IUGR kidneys. To prove this hypothesis, we induced asymmetric IUGR through bilateral uterine artery ligation of the pregnant rat. We found that uteroplacental insufficiency significantly reduced glomeruli number while increasing TUNEL staining and caspase-3 activity in the IUGR kidney. A significant decrease in Bcl-2 mRNA and a significant increase in Bax and p53 mRNA further characterized the IUGR kidney. Because altered p53 CpG methylation affects p53 expression, we analyzed p53 promoter CpG methylation using methylation-sensitive restriction enzymes and real-time PCR. Uteroplacental insufficiency specifically decreased CpG methylation of the renal p53 BstU I site promoter without affecting the Hha I or the Aci I sites. Uteroplacental insufficiency also induced a relative hypomethylation from exon 5 to exon 8, which was associated with deceased mRNA levels of DNMT1. We conclude that uteroplacental insufficiency alters p53 DNA CpG methylation, affects mRNA levels of key apoptosis-related proteins, increases renal apoptosis, and reduces glomeruli number in the IUGR kidney. We speculate that these changes represent mechanisms that contribute to the fetal origins of adult disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869365     DOI: 10.1152/ajpregu.00201.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  76 in total

Review 1.  Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?

Authors:  James A Armitage; Imran Y Khan; Paul D Taylor; Peter W Nathanielsz; Lucilla Poston
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

Review 2.  DNA methylation: an epigenetic risk factor in preterm birth.

Authors:  Ramkumar Menon; Karen N Conneely; Alicia K Smith
Journal:  Reprod Sci       Date:  2012-01       Impact factor: 3.060

Review 3.  Epigenetics and developmental programming of adult onset diseases.

Authors:  Lee O'Sullivan; Alexander N Combes; Karen M Moritz
Journal:  Pediatr Nephrol       Date:  2012-12       Impact factor: 3.714

4.  Developmental programming of the metabolic syndrome - critical windows for intervention.

Authors:  Mark H Vickers
Journal:  World J Diabetes       Date:  2011-09-15

5.  IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization.

Authors:  Lisa A Joss-Moore; Yan Wang; Elizabeth M Ogata; Anthony J Sainz; Xing Yu; Christopher W Callaway; Robert A McKnight; Kurt H Albertine; Robert H Lane
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-03-21

Review 6.  Developmental processes and the induction of cardiovascular function: conceptual aspects.

Authors:  Mark A Hanson; Peter D Gluckman
Journal:  J Physiol       Date:  2005-02-24       Impact factor: 5.182

Review 7.  The developmental origins of adult disease.

Authors:  Peter D Gluckman; Mark A Hanson; Catherine Pinal
Journal:  Matern Child Nutr       Date:  2005-07       Impact factor: 3.092

Review 8.  Prenatal programming-effects on blood pressure and renal function.

Authors:  Eberhard Ritz; Kerstin Amann; Nadezda Koleganova; Kerstin Benz
Journal:  Nat Rev Nephrol       Date:  2011-02-01       Impact factor: 28.314

Review 9.  Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?

Authors:  Graham C Burdge; Karen A Lillycrop; Alan A Jackson
Journal:  Br J Nutr       Date:  2008-12-12       Impact factor: 3.718

10.  Placental insufficiency associated with loss of Cited1 causes renal medullary dysplasia.

Authors:  Duncan B Sparrow; Scott C Boyle; Rebecca S Sams; Bogdan Mazuruk; Li Zhang; Gilbert W Moeckel; Sally L Dunwoodie; Mark P de Caestecker
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.